N. Conti, Eugen Bleuler and the beginnings of psychodinamic psychopathology], Vertex B Aires Argent. févr, vol.21, issue.89, pp.70-71, 2010.

D. Cameron and . Early, EARLY SCHIZOPHRENIA, American Journal of Psychiatry, vol.95, issue.3, pp.567-82, 1938.
DOI : 10.1176/ajp.95.3.567

L. Vd, A. Velligan, D. , and A. Ld, Negative Symptoms in Schizophrenia: The Importance of Identification and Treatment Disponible sur, Psychiatr Times [Internet]. 1 mars, vol.25, issue.3, p.1147581, 2008.

S. Farrelly, D. Jeffery, N. Rüsch, P. Williams, G. Thornicroft et al., Conclusions, Psychological Medicine, vol.24, issue.10, pp.1-10, 2015.
DOI : 10.1016/S0140-6736(08)61817-6

P. Et, . Des, and . Mentales, Enqu te men e par Ipsos Public Affairs pour FondaMental

N. Charrier, K. Chevreul, and I. Durand-zaleski, The cost of schizophrenia: a literature review, Ence?phale. mai, vol.39, issue.1, pp.49-56, 2013.

S. Hautecouverture, F. Limosin, and F. Rouillon, Epidemiology of schizophrenic disorders]. Presse Médicale Paris Fr 1983, mars, vol.35, issue.3 2, pp.461-469, 2006.

K. Olsen and B. Rosenbaum, Prospective investigations of the prodromal state of schizophrenia: review of studies, Acta Psychiatrica Scandinavica, vol.1, issue.413, pp.247-72, 2006.
DOI : 10.1037//0022-006X.52.1.63

A. Yung and P. Mcgorry, The Prodromal Phase of First-episode Psychosis: Past and Current Conceptualizations, Schizophrenia Bulletin, vol.22, issue.2, pp.353-70, 1996.
DOI : 10.1093/schbul/22.2.353

D. Forti, M. Lappin, J. Murray, and R. , Risk factors for schizophrenia ??? All roads lead to dopamine, European Neuropsychopharmacology, vol.17, issue.2, pp.101-108, 2007.
DOI : 10.1016/j.euroneuro.2007.02.005

D. Eyles, J. Feldon, and U. Meyer, Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models, Translational Psychiatry, vol.361, issue.2, p.81, 2012.
DOI : 10.1016/S0140-6736(03)12323-9

S. Stahl, Beyond the Dopamine Hypothesis to the NMDA Glutamate Receptor Hypofunction Hypothesis of Schizophrenia, CNS Spectrums, vol.148, issue.04, pp.265-273, 2007.
DOI : 10.1176/ajp.148.10.1301

D. 'amour-horvat, V. Leyton, and M. , Impulsive actions and choices in laboratory animals and humans: effects of high vs. low dopamine states produced by systemic treatments given to neurologically intact subjects, Front Behav Neurosci, vol.8, p.432, 2014.

A. Meyer-lindenberg, J. Buckholtz, B. Kolachana, A. Hariri, L. Pezawas et al., Neural mechanisms of genetic risk for impulsivity and violence in humans, Proceedings of the National Academy of Sciences, vol.158, issue.11, pp.6269-74, 2006.
DOI : 10.1176/appi.ajp.158.11.1809

A. Whitton, M. Treadway, and D. Pizzagalli, Reward processing dysfunction in major depression, bipolar disorder and schizophrenia, Current Opinion in Psychiatry, vol.28, issue.1, pp.7-12, 2015.
DOI : 10.1097/YCO.0000000000000122

E. Helmes and J. Landmark, Subtypes of Schizophrenia: A Cluster Analytic Approach, The Canadian Journal of Psychiatry, vol.4, issue.10, pp.702-710, 2003.
DOI : 10.1176/ajp.145.1.57

R. Tandon and W. Carpenter, DSM-5 Status of Psychotic Disorders: 1 Year Prepublication, Schizophrenia Bulletin, vol.168, issue.5, pp.369-70, 2012.
DOI : 10.1176/appi.ajp.2011.10121816

S. Ruhrmann, F. Schultze-lutter, and J. Klosterkötter, Probably at-risk, but certainly ill ??? Advocating the introduction of a psychosis spectrum disorder in DSM-V, Schizophrenia Research, vol.120, issue.1-3, pp.1-323, 2010.
DOI : 10.1016/j.schres.2010.03.015

C. Obacz, N. Jay, F. Ligier, and B. Kabuth, Clinique de l???enfance d???une population d???adultes schizophr??nes. ??tude r??trospective ?? propos de 50??cas, Neuropsychiatrie de l'Enfance et de l'Adolescence, vol.60, issue.7-8, pp.7-8526, 2012.
DOI : 10.1016/j.neurenf.2012.06.007

S. Giezendanner, S. Walther, N. Razavi, C. Van-swam, M. Fisler et al., Alterations of White Matter Integrity Related to the Season of Birth in Schizophrenia: A DTI Study, PLoS ONE, vol.31, issue.9, p.75508, 2013.
DOI : 10.1371/journal.pone.0075508.s003

P. Schwartz, Season of birth in schizophrenia: A maternal???fetal chronobiological hypothesis, Medical Hypotheses, vol.76, issue.6, pp.785-93, 2011.
DOI : 10.1016/j.mehy.2011.02.019

L. Cai, C. Wan, L. He, S. Jong, . De et al., Psychosis and Gestational Influenza: Meta-Analysis, Med Chem Shariqah United Arab Emir. 29 avr, 2015.

G. Anderson and M. Maes, Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.42, pp.5-19, 2013.
DOI : 10.1016/j.pnpbp.2012.06.014

J. Ballon, K. Dean, and K. Cadenhead, Obstetrical complications in people at risk for developing schizophrenia, Schizophrenia Research, vol.98, issue.1-3, pp.1-3307, 2008.
DOI : 10.1016/j.schres.2007.05.011

P. Harrison, Schizophrenia Susceptibility Genes and Neurodevelopment, Biological Psychiatry, vol.61, issue.10, pp.1119-1139, 2007.
DOI : 10.1016/j.biopsych.2007.02.021

T. Karl and J. Arnold, Schizophrenia: a consequence of gene-environment interactions?, Front Behav Neurosci, vol.8, p.435, 2014.

F. Rivollier, L. Lotersztajn, B. Chaumette, M. Krebs, and O. Kebir, Epigenetics of schizophrenia: a review, Ence?phale. oct, vol.40, issue.5, pp.380-386, 2014.

J. Coyle, Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis, Cellular and Molecular Neurobiology, vol.157, issue.9, pp.4-6365, 2006.
DOI : 10.1001/archpsyc.1995.03950220039008

J. Stone, F. Day, H. Tsagaraki, I. Valli, M. Mclean et al., Glutamate Dysfunction in People with Prodromal Symptoms of Psychosis: Relationship to Gray Matter Volume, Biological Psychiatry, vol.66, issue.6, pp.533-542, 2009.
DOI : 10.1016/j.biopsych.2009.05.006

E. Plitman, S. Nakajima, C. De-la-fuente-sandoval, P. Gerretsen, M. Chakravarty et al., Glutamate-mediated excitotoxicity in schizophrenia: A review, European Neuropsychopharmacology, vol.24, issue.10, pp.1591-605, 2014.
DOI : 10.1016/j.euroneuro.2014.07.015

C. De-la-fuente-sandoval, P. León-ortiz, R. Favila, S. Stephano, D. Mamo et al., Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis, Neuropsychopharmacology, vol.22, issue.9, pp.1781-91, 2011.
DOI : 10.1002/mrm.21265

O. Okusaga, Accelerated aging in schizophrenia patients: the potential role of oxidative stress, Aging Dis. août, vol.5, issue.4, pp.256-62, 2014.

S. Garside, J. Furtado, and M. Mazurek, Dopamine???glutamate interactions in the striatum: behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms, Neuroscience, vol.75, issue.4, pp.1065-74, 1996.
DOI : 10.1016/0306-4522(96)00172-8

J. Stone, P. Morrison, and L. Pilowsky, Review: Glutamate and dopamine dysregulation in schizophrenia ??? a synthesis and selective review, Journal of Psychopharmacology, vol.20, issue.37, pp.440-52, 2007.
DOI : 10.1016/S0920-9964(98)00041-3

R. Tandon, W. Gaebel, D. Barch, J. Bustillo, R. Gur et al., Definition and description of schizophrenia in the DSM-5, Schizophrenia Research, vol.150, issue.1, pp.3-10, 2013.
DOI : 10.1016/j.schres.2013.05.028

N. Korver-nieberg, P. Quee, H. Boos, C. Simons, and G. , The Validity of the DSM-IV Diagnostic Classification System of Non-Affective Psychoses, Australian & New Zealand Journal of Psychiatry, vol.29, issue.12, pp.1061-1069, 2011.
DOI : 10.1016/S0140-6736(09)60995-8

R. Tandon, H. Nasrallah, and M. Keshavan, Schizophrenia, ???just the facts??? 4. Clinical features and conceptualization, Schizophrenia Research, vol.110, issue.1-3, pp.1-31, 2009.
DOI : 10.1016/j.schres.2009.03.005

T. Smith, C. Weston, and J. Lieberman, Schizophrenia (maintenance treatment), BMJ Clin Evid, 2009.